Combining an immunotherapy with chemotherapy vanquished tumors in mice with glioblastoma, the most aggressive form of brain cancer.May 26, 2023Check out STAT+Sponsored By Michelle Monje/Stanford University via NIH STAT+ | Immunotherapy turned brain cancers from 'cold' to 'hot' in mouse study, as clinical trials advance The study showed the treatment cranked tumors from cold to hot enough for immune cells to be able to recognize brain cancers. By Andrew Joseph STAT+ | Bristol drug reduces reliance on transfusions for people with chronic blood disorder The therapy nearly doubled the treatment benefit compared to standard therapy for certain patients with myelodysplastic syndrome. By Adam Feuerstein STAT+ | Opinion: An overlooked way to make participants in clinical trials look more like America About 30 million Americans, 59% of whom are members of racial and ethnic subgroups, receive care in a group of safety-net clinics. By Gloria Coronado and Leslie Bienen More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments